First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations
Clinical trial NCT04409145 · TERMINATED
Trial details
- NCT number
- NCT04409145
- Sponsor
- Venthera, Inc., a BridgeBio company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-04-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.